Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Abilia AS
AS
Active
Org 936869335
Tevlingveien 23, 1081
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1985 · 41 years old
30 employees
www.abilia.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Abilia AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
239M
179M
120M
60M
0M
2020: 85M
85M
2020
2021: 93M (+9% vs 2020)
93M
+9%
2021
2022: 109M (+17% vs 2021)
109M
+17%
2022
2023: 146M (+34% vs 2022)
146M
+34%
2023
2024: 192M (+32% vs 2023)
192M
+32%
2024
EBITDA
NOK millions
83M
63M
42M
21M
0M
2020: 23M
23M
2020
2021: 33M (+43% vs 2020)
33M
+43%
2021
2022: 40M (+21% vs 2021)
40M
+21%
2022
2023: 67M (+68% vs 2022)
67M
+68%
2023
2024: 15M (-78% vs 2023)
15M
-78%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
192 306
145 638
109 313
92 655
84 925
Staff expenses
−27 208
−18 392
−17 818
−17 242
−15 650
EBITDA
15 003
66 634
40 412
32 620
23 125
Depreciation & amort.
−53
−913
−917
−1 247
−1 309
EBIT
14 950
65 721
39 495
31 373
21 816
Net financials
2 608
1 927
981
796
537
Profit before tax
17 558
67 648
40 476
32 169
22 353
Tax
3 906
14 908
8 927
7 089
4 913
Net profit
13 652
52 740
31 549
25 079
17 440
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
152 860
112 057
88 225
77 760
49 368
Equity
55 354
41 701
28 961
28 412
33 333
Long-term debt
0
0
0
0
0
Short-term debt
97 325
70 113
58 984
48 993
15 439
Total debt
97 325
70 113
58 984
48 993
15 439
Financial ratios
5-year trend
EBITDA margin
7,8 %
This company
15,8 %
Market median
This company
Market median
51% below market
2020
2024
Equity ratio
36,2 %
This company
38,2 %
Market median
This company
Market median
5% below market
2020
2024
Return on equity
24,7 %
This company
18,4 %
Market median
This company
Market median
34% above market
2020
2024
Net profit margin
7,1 %
This company
8,1 %
Market median
This company
Market median
12% below market
2020
2024
Asset turnover
1,26×
This company
1,12×
Market median
This company
Market median
12% above market
2020
2024
Debt / equity
1,76×
This company
0,62×
Market median
This company
Market median
184% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Abilia AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
